ישראל - עברית - Ministry of Health

lapidot medical import and marketing ltd - sodium chloride 0.9 g / 100 ml - solution for injection - sodium chloride - plasma isotonic fluid repacement. vehicle solution for supplementary medication fluid and electrolyte replacement ,hypochloremic alkalosis and chloride losses, externally for wound irrigation and moistening of wound dressings,

ישראל - עברית - Ministry of Health

teva medical marketing ltd. - sodium chloride 9 mg/ml - solution for infusion - sodium chloride - a source of water and electrolytes. also indicated for use as a priming solution in hemodialysis procedures.

ישראל - עברית - Ministry of Health

neopharm (israel) 1996 ltd - calcium chloride 27 mg / 100 ml; lactic acid as sodium 0.533 g / 100 ml - solution for injection - combinations of electrolytes - isotonic injectable solution.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - aluminium chlorohydroxide complex solution; methylprednisolone acetate; neomycin sulfate; sulfur - תרחיץ - methylprednisolone acetate 2.5 mg/ml; neomycin sulfate 2.5 mg/ml; sulfur 50 mg/ml; aluminium chlorohydroxide complex solution 200 mg/ml - methylprednisolone - methylprednisolone - acne.

ישראל - עברית - Ministry of Health

cts ltd - lacosamide 10 mg / 1 ml - solution for infusion - lacosamide - vimpat is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy aged 16 years and older.vimpat solution for infusion is an alternative for patients when oral administration is temporary not feasible.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - salbutamol as sulfate - solution for inhalation - salbutamol as sulfate 5 mg/ml - selective beta-2 adrenoreceptor agonists - treatment of severe acute asthma (status asthmaticus) and other forms of bronchospasm.

ישראל - עברית - Ministry of Health

inovamed ltd - ondansetron as hydrochloride dihydrate 2 mg / 1 ml - solution for injection - ondansetron - adults:ondansetron inovamed is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. ondansetron inovamed is indicated for the prevention and treatment of post-operative nausea and vomiting (ponv). paediatric population:ondansetron inovamed is indicated for the management of chemotherapy-induced nausea and vomiting (cinv) in children aged ?6 months, and for the prevention and treatment of ponv in children aged ?2 years.

ישראל - עברית - Ministry of Health

perrigo israel pharmaceuticals ltd - granisetron as hydrochloride - solution for injection - granisetron - for the treatment of nausea and vomiting associated with antineoplastic therapy.

ישראל - עברית - Ministry of Health

teva pharmaceutical indust.ltd - granisetron as hydrochloride 3 mg / 3 ml - solution for infusion - granisetron - for the prevention and control of nausea and vomiting induced by cytostatic therapy (chemotherapy and radiotherapy).

ישראל - עברית - Ministry of Health

teva pharmaceutical indust.ltd - palonosetron as hydrochloride 0.05 mg / 1 ml - solution for injection - palonosetron - prevention of chemotherapy - induced nausea and vomiting (cinv).